Benign and malignant vulvar pathology. A 15 year retrospective study

Authors

  • María Jimena Fernandez Tapia Luis C. Lagomaggiore Hospital, Mendoza, Argentina
  • Adriana Senarega Luis C. Lagomaggiore Hospital, Mendoza, Argentina
  • Jorgelina Vidal Luis C. Lagomaggiore Hospital, Mendoza, Argentina
  • Carla Chessé Luis C. Lagomaggiore Hospital, Mendoza, Argentina
  • María Celeste Abaca Luis C. Lagomaggiore Hospital, Mendoza, Argentina
  • Carolina Innocenti Luis C. Lagomaggiore Hospital, Mendoza, Argentina
  • Viviana Parra Luis C. Lagomaggiore Hospital, Mendoza, Argentina

Keywords:

vulva, vulvar inflammatory injuries, HPV, vulvar neoplasms, precancerous conditions

Abstract

Background: Vulva can be seat of benign, malignant and non-neoplastic pathologies. Statistics in literature are limited.

Objective: To determine vulvar lesions prevalence biopsied at vulvar pathology consultation at Dermatology Unit of Hospital Lagomaggiore from Mendoza, and describe its clinical and histological characteristics.

Design: A descriptive, retrospective, observational and cross-sectional study was performed.

Materials and methods: We collected data from patients evaluated and biopsied in vulvar pathology consultation at Dermatology Unit of Hospital Lagomaggiore from Mendoza, since July 2002 to July 2017. We studied variables such as age, lesion location, evolution time, histological diagnosis and clinical-pathological correlation.

Results: A total of 2671 patients were included and 214 lesions were submitted to biopsy (8.01%). The mean age was 55.64 years (± 14.44 years). Inflammatory pathology was the most frequently (n = 72; 33.64%) and lichen sclerosus was the majority within it (n = 30; 41.67%). 90% of the patients were over 50 years old, with a higher risk of developing this condition than younger than 50 years (OR 4.37; p = 0.003). Squamous cell carcinoma (SCC) represented 75.51% (n = 37) of malignant tumors. Patients older than 50 years showed an increased risk of invasive forms (OR 1.18; p = 0.03). 28.97% (n = 62) of the patients did not know evolution time of the lesion.

Conclusions: Frequency of vulvar dermatosis observed in our hospital coincides with the literature consulted, with a significant percentage of malignant and premalignant pathologies. We emphasize the impor-tance of vulvar region examination for early diagnosis and treatment.

Author Biographies

María Jimena Fernandez Tapia, Luis C. Lagomaggiore Hospital, Mendoza, Argentina

Dermatology Resident Physician

Adriana Senarega, Luis C. Lagomaggiore Hospital, Mendoza, Argentina

Dermatology Resident Physician

Jorgelina Vidal, Luis C. Lagomaggiore Hospital, Mendoza, Argentina

Head of Residents, Dermatology Service. Professor of the Faculty of Medical Sciences, National University of Cuyo

Carla Chessé, Luis C. Lagomaggiore Hospital, Mendoza, Argentina

Resident doctor

María Celeste Abaca, Luis C. Lagomaggiore Hospital, Mendoza, Argentina

Resident Physician

Carolina Innocenti, Luis C. Lagomaggiore Hospital, Mendoza, Argentina

Dermatopathologist

Viviana Parra, Luis C. Lagomaggiore Hospital, Mendoza, Argentina

Head of the Dermatology Service. Professor of Dermatology, Faculty of Medical Sciences, National University of Cuyo

References

I. Heller DS. Benign tumors and tumor-like lesions of the vulva.Clin Obstet Gynecol 2015;58:526-535.

II. Mohan H, Kundu R, Arora K, Punia RS, et ál. Spectrum of vulvar lesions: a clinicopathologic study of 170 cases. Int J Reprod Contracept Obs Gynecol 2014;3:175-180.

III. Anzola GF, Lobo CJ, Márquez SM, Jurado J. Neoplasias malignas de vulva. Incidencia registrada en el servicio oncológico hospitalario de los seguros sociales. Rev Venez Oncol 2015;27:232-238.

IV. Xiao X, Meng YB, Bai P, Zou J, et ál. Vulvar cancer in China: epidemiological features

V. Renaud-Vilmer C, Dehen L, de Belilovsky C, Cavelier-Balloy B. Patología vulvar. EMC-Dermatología 2015;49:1-20.

VI. Maldonado VA. Benign vulvar tumors. Best Pract Res Clin Obstet Gynaecol 2014;28:1088-1097.

VII. Ramesh N, Anjana A, Kusum N, Kiran A, et ál. Overview of benign and malignant tumours of female genital tract. J App Pharm Sci 2013;3:140-149.

VIII. Allbritton JI. Vulvar neoplasms, benign and malignant. Obstet Gynecol Clin North Am 2017; 44:339-352.

IX. Bigby SM, Eva LJ, Leng Fong K, Jones RW. The natural history of vulvar intraepithelial neoplasia, differentiated type: evidence for progression and diagnostic challenges. Int J Gynecol Pathol 2016;35:574-584.

X. Hoang LN, Park KJ, Soslow RA, Murali R. Squamous precursor lesions of the vulva : current classification and diagnostic challenges. Pathology 2016;8:291-302.

XI. Bornstein J, Bogliatto F, Haefner HK, Stockdale CK, et ál. The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) Terminology of Vulvar Squamous Intraepithelial Lesions. Obstet Gynecol 2016;127:264-268.

XII. Halonen P, Jakobsson M, Heikinheimo O, Riska A, et ál. Lichen sclerosus and risk of cancer. Int J Cancer 2017;140:1998-2002.

XIII. Alasino M, García Llaver V, Parra V, Aredes Á, et ál. Tumores no espinocelulares de vulva. Incidencia en ocho años. Dermatol Argent 2010;17:277-283.

XIV. López N, Viayna E, San Martin M, Perulero N. Estimación de la carga epidemiológica de patologías asociadas a 9 genotipos del virus del papiloma humano en España: revisión de la literatura. Vacunas 2017;18:36-42.

Published

2018-06-01

Issue

Section

Original Articles